Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of Acinetobacter baumannii AB1054 OXA-23 assessed as minimum concentration of compound needed to reduce the MIC of meropenem to 8 ug/ml
Assay data:26 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of Acinetobacter baumannii OXA-23 using nitrocefin as substrate preincubated for 10 mins followed by substrate addition measured every 10 secs for 10 mins by spectrophotometrically analysis
Assay data:2 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of Acinetobacter baumannii OXA-24 Y112A/M223A mutant by spectrophotometric method relative to control
Assay data:1 Tested
Inhibition of Acinetobacter baumannii OXA-24 Y112A mutant by spectrophotometric method relative to control
Inhibition of OXA-23 in carbapenem-resistant Acinetobacter baumannii ATCC 17978 transfected with pET-RA-KmR plasmid encoding rifampicin and kanamycin resistance assessed as potentiation of imipenem-induced antibacterial activity by measuring imipenem MIC at 16 ug/mL in Mueller-Hinton broth by CLSI protocol based method (Rvb = 8 ug/mL)
Assay data:9 Tested
Inhibition of Acinetobacter baumannii OXA-24
Inhibition of beta-lactamase OXA-23 in Acinetobacter baumannii ST2 assessed as potentiation of sulbactam-induced antibacterial activity by measuring sulbactam MIC at 8 ug/ml
Inhibition of beta-lactamase OXA-23 in Acinetobacter baumannii ST2 assessed as potentiation of cefepime-induced antibacterial activity by measuring cefepime MIC at 8 ug/ml
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-15 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 8 ug/ml co-administered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
SummaryRelated BioAssays by Target
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-15 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 6 ug/ml co-administered with 6 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-15 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 4 ug/ml co-administered with 8 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-15 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 4 ug/ml co-administered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-10 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 8 ug/ml co-administered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-10 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 6 ug/ml co-administered with 6 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-10 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 4 ug/ml co-administered with 8 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-10 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 4 ug/ml co-administered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-8 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 8 ug/ml co-administered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-8 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 6 ug/ml co-administered with 6 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-8 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 4 ug/ml co-administered with 8 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Inhibition of beta-lactamase in extended-spectrum b-lactamase producing Acinetobacter baumannii S-8 assessed as potentiation of cefpirome-induced antibacterial activity by measuring cefpirome MIC at 4 ug/ml co-administered with 4 ug/ml sulbactam incubated for 16 to 20 hrs by CLSI method
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on